πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,022 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9346822

Thienopyrimidine compounds and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9326946

Laminated tablet and manufacturing method therefor

Takeda Pharmaceutical Company Limited Β· Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9321757

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9320714

Tablet

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9315458

Nitrogen-containing heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9303045

5-HT3 receptor antagonists

Takeda Pharmaceutical Company Limited Β· Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9296746

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9290456

Pyridazinone compounds and their use as DAAO inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9278938

Production method of imidazole derivatives

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9278931

Cyclopropaneamine compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9265730

Stable solid preparations

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9260500

Peptide and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9241910

Orally-disintegrating solid preparation

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9238639

Aromatic ring compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9226921

Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9221836

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9212147

Dihydroxy aromatic heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9212149

Substituted 2-amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9199963

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9200051

Peptide compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9193709

1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative di

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9187497

Substituted pyrido[3,2-e]pyrrolo[1,2-a]pyrazines as inhibitors of poly(ADP-ribose)polymera

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9186411

Pharmaceutical composition

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9187453

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted